- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Evaluation of glycemic control, arterial stiffness, and hypertension improves risk of macrovascular complications
China: A recent study published in Cardiovascular Diabetology has indicated the clinical importance of the combined evaluation of glycemic and hypertension control and arterial stiffness to improve the risk of macrovascular complications among patients with type 2 diabetes.
In type 2 diabetes patients, blood pressure, glycemic control, and arterial stiffness are reported to be risk factors for macrovascular complications. Adverse macrovascular events include cerebrovascular disease, coronary heart disease, and peripheral artery disease. They have become the primary cause of impaired life quality and mortality in diabetes, resulting in severe health and economic burden.
Against the above background, Zhiyuan Wu, Capital Medical University, Youanmen Street, Beijing, China, and their colleague, therefore, aimed to examine the combined association of glycemic control, arterial stiffness, and hypertension status with diabetic macrovascular complications.
For this purpose, the researchers enrolled 1870 diabetes patients from the Beijing Health Management Cohort. They were then followed for the onset of macrovascular complications. They proposed a composite risk score (0–4) by the severity of arterial stiffness, hypertension status, and poor glycemic control. The hazard ratio (HR) was estimated using the hazard ratio (HR).
The authors reported the following findings:
· The mean age of this population was 59.90 years. During a median follow-up of 4.0 years, 19.2% of patients developed macrovascular complications.
· Patients with severe arterial stiffness and poor glycemic control, compared to the standard arterial stiffness and good glycemic control group had the greatest risk of macrovascular complications (HR: 2.73).
· Patients wuth hypertension and severe arterial stiffness had the highest risk (HR: 2.69).
· Patients with a composite score > 2 had a significantly increased risk of macrovascular complications.
"Findings from longitudinal cohort study suggested that the combined evaluation of glycemic control, arterial stiffness, and hypertension status could improve the risk stratification of macrovascular complications in diabetes patients," the researchers wrote in their study. Among patients with poor glycemic control or hypertension, the effect becomes notable from the moderate arterial stiffness.
"This provided novel insights into the preventive strategies against macrovascular complications from the perspective of combined intervention of glucose metabolism and arterial function."
In addition, the authors also established a cumulative and weighted risk score by arterial stiffness, hypertension status, and glycemic control for the risk stratification of diabetic macrovascular complications.
Reference:
Wu, Z., Yu, S., Zhang, H. et al. Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes. Cardiovasc Diabetol 21, 262 (2022). https://doi.org/10.1186/s12933-022-01696-1
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751